Related Experiment Video
Updated: Dec 2, 2025
10:12
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
23.1K
Compounding for women's health: a compounder's perspective - need, regulations, and future
Climacteric : the Journal of the International Menopause Society
|November 2, 2020
Summary
Compounding pharmacies create personalized medications for women's health, adhering to strict guidelines. Future innovations like pharmacogenomics and 3D printing promise to revolutionize personalized medicine.
Area of Science:
- Pharmacy and Pharmaceutical Sciences
- Personalized Medicine
- Women's Health
Background:
- Compounding pharmacies create customized medications tailored to individual patient needs.
- These preparations address conditions such as menopause and other women's health issues.
- Compounded medications differ from commercial drugs by personalizing allergies, dosages, and delivery methods.
Purpose of the Study:
- To highlight the role of compounding in personalized medicine, particularly for women's health.
- To discuss the regulatory standards governing pharmaceutical compounding.
- To explore future advancements in compounding, including pharmacogenomics and 3D printing.
Main Methods:
- Review of current practices and regulatory standards in pharmaceutical compounding.
- Analysis of the personalized aspects of compounded medications versus commercial drugs.
- Exploration of emerging technologies and their potential impact on compounding.
Main Results:
- Compounding pharmacies provide essential personalized treatments, especially for women's health conditions.
- Adherence to guidelines from state pharmacy boards and the FDA ensures safe compounding practices.
- Personalized formulation addresses patient-specific allergies, doses, and preferences.
Conclusions:
- Compounding pharmacies will continue to provide unique medications unmet by the commercial sector.
- Pharmacogenomics and 3D printing are poised to significantly advance personalized medicine through compounding.
- These innovations offer new avenues for tailored patient treatment and drug formulation.
More Related Videos
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
17.4K
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.8K
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
84
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
84
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
96
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
96
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
114
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
114
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
96
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
96
01:24Dosage Regimen: Individualization
90
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
90
01:28Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K